Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.
about
A pseudo-tRNA modulates antibiotic resistance in Bacillus cereusThe lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureusReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsRelationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infectionsAntimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of BacteriaMolecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureusCellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteriaEvolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKRDNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.Intermediate-type vancomycin resistance (VISA) in genetically-distinct Staphylococcus aureus isolates is linked to specific, reversible metabolic alterations.Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureusFirst report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.Teicoplanin stress-selected mutations increasing sigma(B) activity in Staphylococcus aureus.Septic arthritis caused by vancomycin-intermediate Staphylococcus aureus.Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureusAccessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycinMethicillin and Vancomycin Resistant S. aureus in Hospitalized Patients.An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus.Deciphering the magainin resistance process of Escherichia coli strains in light of the cytosolic proteomeEffect of low temperature on growth and ultra-structure of Staphylococcus sppAntimicrobial activity of a bovine myeloid antimicrobial peptide (BMAP-28) against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus.The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibilityPeptidoglycan architecture of Gram-positive bacteria by solid-state NMR.In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureusMultivalent artificial opsonin for the recognition and phagocytosis of Gram-positive bacteria by human phagocytes.Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure.Genetics of antimicrobial resistance in Staphylococcus aureus.Vancomycin-resistant Staphylococcus aureus isolate from a patient in PennsylvaniaTranscriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Phenotypic variants of staphylococci and their underlying population distributions following exposure to stress.
P2860
Q21134135-1C652CFA-1FD6-4718-960B-CAFEF2F67FB0Q21263072-A174AF54-157C-42C1-9D5D-031CC20E8090Q24646677-AAD09CBF-F846-422F-8A66-A8969F45E9C8Q27011138-90E8846C-70E5-4DDE-8112-E4CAE60E2C63Q28072687-25841802-11F6-4C9F-8157-31E22E785D7FQ28078930-A5765E25-6039-4A97-83D6-C45D92C989D9Q28217016-3D9A8833-C694-4AAA-AFF1-0F808FE78A77Q28477900-BE772A3C-995A-44FC-A205-1751159D5A5AQ33220466-313760F6-137E-49AD-8955-379B21A374DBQ33261667-D7EB19D6-ED4F-493B-A919-D3059BE98F04Q33264418-08CF4F71-1E7E-4D15-80C3-83AD4E3376F1Q33321447-6B326E97-3FB6-4EB5-BD49-E11314E760C6Q33591402-ABCD11BA-A244-4514-A683-393780D42BD5Q33664443-51EB5F52-7878-4113-90A8-B337C04FB188Q33696380-DD7F5A87-3CCD-4D18-B887-A952BD7D712FQ33723258-2565399F-624B-435D-AD02-E7075F8F45DCQ33971217-23317585-B3CE-4BED-821F-B86CF864B75BQ33974326-E00B26FD-1522-422F-B16A-A4AA9DD7621DQ33982248-986887CE-68E8-4FBC-BEF1-0C0D43738054Q34041576-3B816D69-DCE1-4D7E-9C8A-51C275AE0D90Q34057324-98F197AD-EC5E-4EF3-85EC-B43C7814AABCQ34107062-34416609-48B4-4B6D-8033-62CFFA72B042Q34142160-9A6BFAF1-AC5B-4B4C-88CA-773BC5321AEEQ34142416-EF17090E-F349-4A67-BD64-C9BD4286C649Q34145463-6CFEC7A4-EF85-4369-8649-1D9D8A509FBCQ34145802-C4723A1F-FFF2-4D7D-8DC6-83B94C811FB8Q34302821-E7CE3D21-5113-4D6E-AD1C-0EA37C074BFAQ34323128-326DCC64-D731-4CEC-B78D-EAE72F79D95CQ34596835-3F0432C6-9BA3-4113-A7EE-820CA9E59A41Q34632683-3720339D-C57B-4465-BD71-9149998E07CEQ34647068-9D860213-BE65-42D2-93F9-FD72F60E3DE0Q34721614-E6D717C9-085A-43CA-9A79-92CD621AA064Q34747322-96A3B03C-E433-44F5-870B-5A5A22A5694FQ34754245-1951D378-2427-49F2-AB4E-00B1A2A595EBQ34823746-BA2D767A-EEA3-4DF8-A2D8-861C80F3E00BQ34932588-25BB1E09-6E83-4DAA-95FA-033BBBD25F01Q34984662-D3DB7F3A-286B-4489-B939-A82A51E6E94EQ35007120-3629D33C-6599-499A-A366-5CC18461B070Q35023285-5693F599-3D46-42E5-A794-C33687B1703AQ35035440-0AB475C8-C90D-4F08-B21E-D7A3C9717D2D
P2860
Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Contribution of a thickened ce ...... by Staphylococcus aureus Mu50.
@en
Contribution of a thickened ce ...... by Staphylococcus aureus Mu50.
@nl
type
label
Contribution of a thickened ce ...... by Staphylococcus aureus Mu50.
@en
Contribution of a thickened ce ...... by Staphylococcus aureus Mu50.
@nl
prefLabel
Contribution of a thickened ce ...... by Staphylococcus aureus Mu50.
@en
Contribution of a thickened ce ...... by Staphylococcus aureus Mu50.
@nl
P2093
P2860
P1476
Contribution of a thickened ce ...... by Staphylococcus aureus Mu50.
@en
P2093
H Murakami
K Hiramatsu
K Kuwahara-Arai
P2860
P304
P356
10.1128/AAC.44.9.2276-2285.2000
P407
P577
2000-09-01T00:00:00Z